Passage Bio's market cap is currently ―. The company's EPS TTM is $-1.864; its P/E ratio is -0.66; Passage Bio is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -16.79M	$ -27.12M	$ -23.86M	$ -34.34M	$ -28.24M
EBITDA	$ -16.83M	$ -26.54M	$ -23.63M	$ -33.44M	$ -27.71M
Net Income Common Stockholders	$ -16.75M	$ -27.12M	$ -23.86M	$ -34.34M	$ -27.07M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 114.29M	$ 132.78M	$ 151.48M	$ 167.77M	$ 189.61M
Total Assets	$ 150.54M	$ 169.26M	$ 193.70M	$ 213.24M	$ 243.55M
Total Debt	$ 26.29M	$ 26.52M	$ 26.74M	$ 26.95M	$ 27.11M
Net Debt	$ -88.00M	$ -106.26M	$ -124.74M	$ -140.82M	$ -162.50M
Total Liabilities	$ 39.26M	$ 42.98M	$ 43.28M	$ 42.89M	$ 42.18M
Stockholders Equity	$ 111.28M	$ 126.28M	$ 150.41M	$ 170.35M	$ 201.37M
Cash Flow	-
Free Cash Flow	$ -19.53M	$ -19.17M	$ -17.18M	$ -22.45M	$ -24.50M
Operating Cash Flow	$ -19.52M	$ -19.16M	$ -17.08M	$ -22.42M	$ -24.02M
Investing Cash Flow	$ 7.60M	$ 22.45M	$ 13.97M	$ 21.22M	$ -3.36M
Financing Cash Flow	$ 46.00K	-	$ 89.00K	-	$ -588.00K

Currency in USD

Passage Bio Earnings and Revenue History

Income Statement >

Passage Bio Debt to Assets

Balance Sheet >

Passage Bio Cash Flow

Cash Flow >

Passage Bio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing